Article Information
History
- July 2, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marc-Werner Dobenecker1,2,*,
- Vyacheslav Yurchenko1,3,
- Jonas Marcello1,4,
- Annette Becker1,5,
- Eugene Rudensky1,6,
- Natarajan V. Bahnu7,
- Thomas Carrol8,
- Benjamin A. Garcia7,
- Brad R. Rosenberg9,
- Rabinder Prinjha10 and
- Alexander Tarakhovsky1,*
- 1Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA
- 2Now Bristol-Meyers Squibb, Princeton, New Jersey, NJ, USA
- 3Now Life Science Research Centre, University of Ostrava, Czech Republic
- 4Now Centogene AG, Rostock, Germany
- 5Now Arcus Biosciences, Hayward, CA, USA
- 6Now NYU School of Medicine, New York, NY, USA
- 7Epigenetics Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 8Bioinformatics Resource Center, Rockefeller University, New York, NY, USA
- 9Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 10Epinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Stevenage, UK
- ↵* Address for correspondence: Alexander Tarakhovsky, Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065, USA, Phone 212-327-8265, Fax 212-327-8256, e-mail: tarakho{at}rockefeller.edu or Marc-Werner Dobenecker, Drug Discovery Immuno Science, Bristol-Meyers Squibb, Princeton, NJ 08540, USA, Phone 609-252-3657, e-mail: Marc-Werner.Dobenecker{at}BMS.com